You have access
Regulatory decisions pertaining to aprotinin may be putting patients at risk
Paul C. Hébert, Dean A. Fergusson, Brian Hutton, C. David Mazer, Stephen Fremes, Morris Blajchman, Charles MacAdams, George Wells, Jim Robblee, Jean Bussières and Kevin Teoh; for the BART Investigators
Commentary